冠心病慢性心力衰竭患者室性心律失常临床治疗

Clinical treatment of ventricular arrhythmias in patients with coronary heart disease and chronic heart failure

目的:探讨冠心病慢性心力衰竭患者室性心律失常的临床治疗。方法:收治冠心病慢性心力衰竭患者128例,回顾性分析其临床资料。结果:左心室内径≥60 mm的室性心律失常发生率显著高于左心室内径<60 mm的患者(P<0.05);室性心律失常患者BNP、LVEF与无室性心律失常患者差异有统计学意义(P<0.05);使用胺碘酮室性心律失常患者的β受体阻滞剂剂量与没有使用胺碘酮室性心律失常患者差异有统计学意义(P<0.05)。结论:冠心病慢性心力衰竭患者室性心律失常发生率较高,且抗心律失常、治疗心衰药物等之间存在一定的联系。

Objective:To explore the clinical treatment of ventricular arrhythmias in patients with coronary heart disease andchronic heart failure.Methods:128 patients with chronic heart failure and coronary heart disease were selected.The clinical datawere retrospectively analyzed.Results:The incidence of ventricular arrhythmias in patients with the left ventricular diametergreater than 60 mm was significantly higher than patients with left ventricular diameter less than 60 mm(P<0.05).BNP and LVEFin patients with ventricular arrhythmias had worse differences with the patients without ventricular arrhythmias(P<0.05).The betablocker dose in patients with ventricular arrhythmias treated with amiodarone was greatly different from the patients who did notuse amiodarone for ventricular arrhythmias(P<0.05).Conclusion:The incidence of ventricular arrhythmias in patients withcoronary heart disease and chronic heart failure was high.There was a certain relationship between anti arrhythmia drugs anddrugs for heart failure.